New Directions in Point-of-Care and Critical Care Testing:
Innovation, Controversies, and Partnerships
23rd International Symposium, September 22-25, 2010
Marriott Copley Place Hotel, Boston, Massachusetts

The Evolution of Quality and Safety in the Healthcare Marketplace
Gregg S. Meyer, MD, MSc, Senior Vice President for Quality and Safety, Massachusetts General Hospital, Boston, MA

INTEGRATING POCT INTO PATIENT CARE PATHWAYS AND PATIENT OUTCOMES

Cardiac Markers at POC: What is the Evidence?
Robert Christenson, PhD, University of Maryland, Baltimore, MD

Point-of-Care Testing: Care Closer to Home
Christopher Price, PhD, University of Oxford, Oxfordshire, United Kingdom

Clinico-Molecular Predictors of Patient Outcomes After Exposure to Respiratory Viral Pathogens
Christopher Woods, MD, MPH, Duke University Medical Center, Durham, NC

Implementation of point of care testing in the ED: A study on decreased throughput times for patients being seen for rapid strepA testing 
Kirsten Halverson, Children’s Hospitals and Clinics of Minnesota, Minneapolis.

MICROBIOLOGY AND INFECTIOUS DISEASE TESTING

POC Testing for Communicable Diseases:  Lessons from HIV
Bernard Branson, MD, CDC-Division of HIV/AIDS Prevention, Atlanta, GA

Suboptimal Accuracy of Rapid Influenza Diagnostic Tests Limits their Potential Benefit
Christine Ginocchio, PhD, North Shore-LIJ Health System Laboratories, Lake Success, NY

Rapid Testing for Influenza at the POC Improves Physician Decision-Making and Subsequent Patient Care
Aleta Bonner, DVM, MD, MSPH, Dell Childrens Medical Center of Central Texas, Austin, TX

Challenges and Opportunities in Developing Diagnostic Tests for Low-Income Settings
William Rodriguez, MD, Daktari Diagnostics, Cambridge, MA

Rheonix CARD™ Technology:  An innovative and fully automated molecular diagnostic device
Richard Montagna, PhD, Rheonix Inc., Ithaca, NY

INNOVATION AND NEW TECHNOLOGIES

Piezofilm Sensors—A Novel Approach to Point-of-Care Immunoassays
Oliver Boucher, Vivacta Limited, Kent, UK

IR2Dx Technology for POCT and Diabetes
Andreas Pfützner, MD, PhD, IR2DX, Germany

Wearable Biomedical Sensors
Chris Lowe, PhD, University of Cambridge, Cambridge, UK

Four step validation procedure for evaluating POCT meters 
Nicola Blount, Cardiff University Health Board, Cardiff, Wales

Validation of point of care test results by assessment of expected analyte relationships
Steven Kazmierczak, PhD, Oregon Health Science University, Portland, OR

POINT OF CARE TESTING PARTNERSHIPS

Implementing POC Testing in the Emergency Department (ED) to Improve Outcomes:  Experience with an ED Satellite Laboratory at the Massachusetts General Hospital (MGH)
Kent Lewandrowski, MD, Massachusetts General Hospital, Boston, MA, USA

Expanding POCT Services: The Importance of Collaboration, Communication, and Compliance
Lou Ann Wyer, MS, MT(ASCP), Sentara Healthcare, Norfolk, VA 

Point-of-care testing, partnerships, and patient identification: Strategies to further improve the bedside glucose testing process
Kimberly Skala, MT(ASCP), Advocate Christ Medical Center, Oak Lawn, IL

Innovative use of point of care testing for chronic kidney disease screening 
Mark Shephard, PhD, Flinders University, Adelaide, Australia

Multidisciplinary project to coordinate bedside glucose testing and patient meals. 
Brad Karon, MD, PhD, Mayo Clinic, Rochester, MN

Resolving discrepant POC PT INR results through an ongoing registered nurse and point of care testing coordinator partnership
Peggy Mann, MT(ASCP), University of Texas Medical Branch, Galveston, TX

CONTROVERSIES IN POC AND CRITICAL CARE TESTING

POC Testing for Antiplatelet Therapy to Assess Bleeding Risk
Pro:  Corinne Fantz, PhD, Emory University School of Medicine, Atlanta, GA
Con: Kenichi Tanaka, MD, Emory University School of Medicine, Atlanta, GA

Glucose Meters Perform Acceptably in Tight Glycemic Control Protocols in ICUs
Pro: Stanley Nasraway, MD, Tufts University School of Medicine, Boston, MA
Con: David Bruns, MD, University of Virginia Medical Center, Charlottesville, VA

Predicted discrepancies between direct reading whole blood biosensors and central lab plasma methods: Predicting and avoiding medical error
Martha Lyon, PhD, University of Calgary, Calgary, Alberta, Canada

Can the qualitative, point-of-care serum pregnancy test be considered obsolete? 
Larissa Furtado, MD, University of Utah Health Sciences Center, Salt Lake City, UT